Zura Bio Ltd

Zura Bio Ltd (Nasdaq: ZURA) is a clinical-stage biopharmaceutical company that completed its de-SPAC merger with JATT Acquisition Corp, sponsored by JATT Acquisition Sponsor LLC, in early 2023. JATT Acquisition Corp conducted its IPO in 2021 and targeted the healthcare and life sciences sector, ultimately combining with Zura Bio, which focuses on developing treatments for immunological and inflammatory diseases. The 10-K filed on March 28, 2023, represents the combined company's first annual report as a publicly traded entity on Nasdaq following the business combination. For full filing history, sponsor details, and deal analytics on Zura Bio and hundreds of other SPAC transactions, sign up for complete data access at SpacDesk.